Real‐world EGFR testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional study

BACKGROUND: Before tyrosine kinase inhibitor (TKI) therapy can be administered in patients with advanced non‐small cell lung cancer (NSCLC), EGFR mutation testing is required. However, few studies have evaluated the extent of EGFR testing in real‐world practice in China. METHODS: A multicenter, obse...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Thorac Cancer
Asıl Yazarlar: Cheng, Ying, Wang, Yan, Zhao, Jun, Liu, Yunpeng, Gao, Hongjun, Ma, Kewei, Zhang, Shucai, Xin, Hua, Liu, Jiwei, Han, Chengbo, Zhu, Zhitu, Chen, Jun, Wen, Fugang, Li, Junling, Zhang, Jie, Zheng, Zhendong, Dai, Zhaoxia, Piao, Hongmei, Li, Xiaoling, Li, Yinyin, Zhong, Min, Ma, Rui, Zhuang, Yongzhi, Xu, Yuqing, Qu, Zhuohui, Yang, Haibo, Pan, Chunxia, Yang, Fan, Zhang, Daxin, Li, Bing
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons Australia, Ltd 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209800/
https://ncbi.nlm.nih.gov/pubmed/30253083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12859
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller